CoachMarc, thanks for the kind words. This particular sub-site within the I-Hub complex really is a good space, with folks from many vantage points chiming in and generally playing well with each other in this sandbox.
Congratulations on figuring out a valid exit-point from the stock. A stock which can have high of six cents and a low of two cents in back-to-back days is the definition of a timing challenge in an overall penny stock market where lots of folks trust in momentum.
As regards the thought of initiating a new position, I would believe:
1. The fourth fiscal quarter drawing to a close in about four weeks is going to show strong sales, as the recent quarterly reporting moved away from saying that the company has no seasonal differentiations to saying that the third fiscal quarter is the low quarter.
2. The rush to market of new products ahead of the initial regulatory guideline should yield a flock of good product reviews and reinforce the prospect of good sales volume in the short run.
3. If there is even a whisper that the proposed legislation to address the FDA matters has a chance of passing, that could fuel a strong rally, as the market right now seems to be anticipating the worst.
4. So why then is the stock in the dumper? It's the capital access problem, compounded by the fact that any debt-conversions will be dilutive, given where the stock is sitting these days. ...coupled with nobody having a sense whether the Gotama folks, the Typenex folks, or the most recent bunch (forgive my laziness in not looking up the name of the 750K lender) want to bet on the company or just realize any proceeds of sale while there are proceeds to be realized.
5. Overall, the challenge with trying to take advantage of a perceived trading opportunity is that it's hard not to be burned by order-execution when bid-ask spreads are high. As regards a more long-term investment opportunity, if you see Trump getting elected, look for restraint upon FDA powers (or any government agency, for that matter), I can see a pathway for VHUB being more likely than not of succeeding in a more constructively regulated marketplace.
6. Almost forgot, you're right about the family-intensive management. The capacity to self-deal, not to mention the risk of not listening to outside advice, presents a real challenge.
Have a good weekend!
